Document Detail

Neuroprotective role of erythropoietin in neonates.
MedLine Citation:
PMID:  22958035     Owner:  NLM     Status:  In-Data-Review    
This review summarizes target populations of neonates for which erythropoietin (Epo) neuroprotective therapy might be of benefit, and the mechanisms by which Epo functions as a neuroprotective agent. Potential risks of Epo are reviewed. Finally, the progression of Epo neuroprotection from preclinical studies to translational studies is discussed.
Sandra Juul
Related Documents :
17291295 - Congenital melanocytic nevi and nevus spilus have a tendency to follow the lines of bla...
17645505 - Peritoneal keratin granulomas complicating endometrial carcinoma: a report of two cases...
1447655 - Pseudomembranous colitis in sickle cell disease responding to exchange transfusion.
17898435 - Occult giant cell arteritis and steroid therapy: how urgent is urgent?
6957105 - Cytologic diagnosis of a case of pulmonary cryptococcosis.
16054855 - Strangulation deaths during 1993-2002 in east delhi (india).
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians     Volume:  25 Suppl 4     ISSN:  1476-4954     ISO Abbreviation:  J. Matern. Fetal. Neonatal. Med.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101136916     Medline TA:  J Matern Fetal Neonatal Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  97-9     Citation Subset:  IM    
Department of Paediatrics, Neonatology Division, University of Washington , Seattle, Washington , USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Biomarkers of brain damage in preterm infants.
Next Document:  SpO(2) and retinopathy of prematurity: state of the art.